Drug combinations in CLL: ibrutinib, idelalisib and more
Results of CheckMate 039 trial of nivolumab in combination with ipilimumab for Hodgkin lymphoma
Tsunami of evidence in CLL
EBMT 2016 presentations overview: GvHD and metabolic syndrome
How does a patient’s personal situation affect CLL treatment choice?